Literature DB >> 29848533

Severe Babesia microti infection presenting as multiorgan failure in an immunocompetent host.

Juan G Ripoll1, Mahrukh S Rizvi2, Rebecca L King3, Craig E Daniels2.   

Abstract

A previously healthy 67-year-old farmer presented to an outside hospital after a 2-week history of non-specific respiratory symptoms. A certain diagnosis was not initially apparent, and the patient was discharged home on a regimen for presumed chronic obstructive pulmonary disease exacerbation. He re-presented to the emergency department with shock and hypoxaemic respiratory failure requiring prompt intubation and fluid resuscitation. He was then transferred to our institution due to multiorgan failure. On arrival, the patient demonstrated refractory shock and worsening acute kidney injury, severe anaemia and thrombocytopaenia. The peripheral smear revealed absence of microangiopathic haemolytic anaemia. A closer review of the smear displayed red blood cell inclusion bodies consistent with babesiosis. The patient was started on clindamycin and loaded with intravenous quinidine, and subsequently transitioned to oral quinine. A red cell exchange transfusion was pursued with improvement of the parasite load. The patient was discharged home on clindamycin/quinine and scheduled for outpatient intermittent haemodialysis. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  adult intensive care; infectious diseases; intensive care; mechanical ventilation

Mesh:

Substances:

Year:  2018        PMID: 29848533      PMCID: PMC5990094          DOI: 10.1136/bcr-2018-224647

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Severe babesiosis and Borrelia burgdorferi co-infection.

Authors:  C Martínez-Balzano; M Hess; A Malhotra; R Lenox
Journal:  QJM       Date:  2012-06-07

2.  Human babesiosis.

Authors:  Edouard Vannier; Peter J Krause
Journal:  N Engl J Med       Date:  2012-06-21       Impact factor: 91.245

3.  Human Babesiosis: Pathogens, Prevalence, Diagnosis and Treatment.

Authors:  Rosalynn Louise Ord; Cheryl A Lobo
Journal:  Curr Clin Microbiol Rep       Date:  2015-09-28

4.  Fulminant babesiosis treated with clindamycin, quinine, and whole-blood exchange transfusion.

Authors:  S E Dorman; M E Cannon; S R Telford; K M Frank; W H Churchill
Journal:  Transfusion       Date:  2000-03       Impact factor: 3.157

5.  A case report of transfusion-induced babesiosis.

Authors:  L C Marcus; J M Valigorsky; W L Fanning; T Joseph; B Glick
Journal:  JAMA       Date:  1982-07-23       Impact factor: 56.272

Review 6.  Red cell exchange transfusion for babesiosis in Rhode Island.

Authors:  Joshua Spaete; Eleni Patrozou; Josiah D Rich; Joseph D Sweeney
Journal:  J Clin Apher       Date:  2009       Impact factor: 2.821

7.  Fever of unknown origin (FUO) due to babesiosis in a immunocompetent host.

Authors:  Burke A Cunha; Yehuda Z Cohen; Brian McDermott
Journal:  Heart Lung       Date:  2008-09-30       Impact factor: 2.210

Review 8.  Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Authors:  Edgar Sanchez; Edouard Vannier; Gary P Wormser; Linden T Hu
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

9.  Severe babesiosis presenting as acute respiratory distress syndrome in an immunocompetent patient.

Authors:  Veena Panduranga; Anupam Kumar
Journal:  Conn Med       Date:  2014-05

10.  Severe Babesia microti Infection in an Immunocompetent Host in Pennsylvania.

Authors:  Jeffrey Genda; Elizabeth A Negron; Mona Lotfipour; Samyuktha Balabhadra; Diana S Desai; David W Craft; Michael Katzman
Journal:  J Investig Med High Impact Case Rep       Date:  2016-08-22
View more
  1 in total

1.  Seroprevalence of six pathogens transmitted by the Ixodes ricinus ticks in asymptomatic individuals with HIV infection and in blood donors.

Authors:  Agnieszka Pawełczyk; Małgorzata Bednarska; Justyna D Kowalska; Beata Uszyńska-Kałuża; Marek Radkowski; Renata Welc-Falęciak
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.